Frontiers | HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
Slides: HIF-PH Inhibitors - Slideset Download | CCO
Hif ph inhibitors for anemia in ckd | PPT
HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond | Nature Reviews Nephrology
Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials - Chemical Science (RSC Publishing)
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD - ScienceDirect
ISN ACT Webinar: Hypoxia inducible factor-prolyl hydroxylase inhibitors (HIF-PHIs) - International Society of Nephrology
A new insight into the treatment of renal anemia with HIF stabilizer | Renal Replacement Therapy | Full Text
Biomedicines | Free Full-Text | HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review
Frontiers | HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
Molecules | Free Full-Text | Recent Advances in Developing Inhibitors for Hypoxia-Inducible Factor Prolyl Hydroxylases and Their Therapeutic Implications
Treating Anemia in CKD in the Era of HIFs: A Ray of Hope? - Renal Fellow Network
Mechanism of action of the HIF inhibitors, blocking different steps of... | Download Scientific Diagram
Selectivity of HIF-PH inhibitors: concerns regarding possible off-target effects | Clinical and Experimental Nephrology
Small-molecule inhibitors of HIF-PHD2: a valid strategy to renal anemia treatment in clinical therapy - MedChemComm (RSC Publishing)
HIF PHD inhibitors and their targets in the active site of HIF prolyl... | Download Scientific Diagram
Frontiers | Possible Role of PHD Inhibitors as Hypoxia-Mimicking Agents in the Maintenance of Neural Stem Cells' Self-Renewal Properties
The oral hypoxia-inducible factor prolyl hydroxylase inhibitor enarodustat counteracts alterations in renal energy metabolism in the early stages of diabetic kidney disease - ScienceDirect
HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond | Nature Reviews Nephrology
Hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitors induce autophagy and have a protective effect in an in-vitro ischaemia model | Scientific Reports
Edgar V. Lerma 🇵🇭 on X: "HIF prolyl hydroxylase inhibitors for the treatment of renal anemia and beyond ca. 2016 from @NatRevNeph #Nephpearls 👉🏼 https://t.co/ay9OS6HsFF https://t.co/4GxsbP3FzS" / X
Anemia of chronic kidney disease: Will new agents deliver on their promise? | Cleveland Clinic Journal of Medicine
Molecules | Free Full-Text | Action Sites and Clinical Application of HIF-1α Inhibitors
